BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 22386723)

  • 41. Conventional high-dose-rate brachytherapy with concomitant complementary IMRT boost: a novel approach for improving cervical tumor dose coverage.
    Duan J; Kim RY; Elassal S; Lin HY; Shen S
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):765-71. PubMed ID: 18164832
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Is there any advantage to three-dimensional planning for vaginal cuff brachytherapy?
    Kim H; Kim H; Houser C; Beriwal S
    Brachytherapy; 2012; 11(5):398-401. PubMed ID: 22301073
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Proposed guidelines for image-based intracavitary brachytherapy for cervical carcinoma: report from Image-Guided Brachytherapy Working Group.
    Nag S; Cardenes H; Chang S; Das IJ; Erickson B; Ibbott GS; Lowenstein J; Roll J; Thomadsen B; Varia M;
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1160-72. PubMed ID: 15519788
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Three-dimensional image-based high-dose-rate interstitial brachytherapy for vaginal cancer.
    Beriwal S; Rwigema JC; Higgins E; Kim H; Houser C; Sukumvanich P; Olawaiye A; Richard S; Kelley JL; Edwards RP; Krivak TC
    Brachytherapy; 2012; 11(3):176-80. PubMed ID: 21665553
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Analytical HDR prostate brachytherapy planning with automatic catheter and isotope selection.
    Frank CH; Ramesh P; Lyu Q; Ruan D; Park SJ; Chang AJ; Venkat PS; Kishan AU; Sheng K
    Med Phys; 2023 Oct; 50(10):6525-6534. PubMed ID: 37650773
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology.
    Pötter R; Haie-Meder C; Van Limbergen E; Barillot I; De Brabandere M; Dimopoulos J; Dumas I; Erickson B; Lang S; Nulens A; Petrow P; Rownd J; Kirisits C;
    Radiother Oncol; 2006 Jan; 78(1):67-77. PubMed ID: 16403584
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Radiography-based treatment planning compared with computed tomography (CT)-based treatment planning for intracavitary brachytherapy in cancer of the cervix: analysis of dose-volume histograms.
    Kim RY; Pareek P
    Brachytherapy; 2003; 2(4):200-6. PubMed ID: 15062127
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of "optimized" treatment planning for tandem and ring, and tandem and ovoids, using high dose rate brachytherapy for cervical cancer.
    Noyes WR; Peters NE; Thomadsen BR; Fowler JF; Buchler DA; Stitt JA; Kinsella TJ
    Int J Radiat Oncol Biol Phys; 1995 Jan; 31(1):79-86. PubMed ID: 7995771
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Variation of treatment planning parameters (D90 HR-CTV, D 2cc for OAR) for cervical cancer tandem ring brachytherapy in a multicentre setting: comparison of standard planning and 3D image guided optimisation based on a joint protocol for dose-volume constraints.
    Jürgenliemk-Schulz IM; Lang S; Tanderup K; de Leeuw A; Kirisits C; Lindegaard J; Petric P; Hudej R; Pötter R;
    Radiother Oncol; 2010 Mar; 94(3):339-45. PubMed ID: 19944471
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Using the computed tomography in comparison to the orthogonal radiography based treatment planning in high dose rate (HDR) brachytherapy in cervical uteri cancer patients; a single institution feasibility study.
    Bahadur YA; El-Sayed ME; El-Taher ZH; Zaza KO; Moftah BA; Hassouna AH; Ghassal NM
    J Egypt Natl Canc Inst; 2008 Mar; 20(1):1-9. PubMed ID: 19847276
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dosimetric impact of interobserver variability in MRI-based delineation for cervical cancer brachytherapy.
    Hellebust TP; Tanderup K; Lervåg C; Fidarova E; Berger D; Malinen E; Pötter R; Petrič P
    Radiother Oncol; 2013 Apr; 107(1):13-9. PubMed ID: 23462706
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Megavoltage computed tomography image-based low-dose rate intracavitary brachytherapy planning for cervical carcinoma.
    Wagner TH; Langen KM; Meeks SL; Willoughby TR; Zeidan OA; Staton RJ; Shah AP; Manon RR; Kupelian PA
    Technol Cancer Res Treat; 2009 Apr; 8(2):123-30. PubMed ID: 19334793
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Conformal brachytherapy planning for cervical cancer using transabdominal ultrasound.
    Van Dyk S; Narayan K; Fisher R; Bernshaw D
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):64-70. PubMed ID: 19250767
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of bladder distension on dose distribution of intracavitary brachytherapy for cervical cancer: three-dimensional computed tomography plan evaluation.
    Cengiz M; Gürdalli S; Selek U; Yildiz F; Saglam Y; Ozyar E; Atahan IL
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):464-8. PubMed ID: 17768014
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of HDR interstitial breast implants planned by conventional and optimized CT-based dosimetry systems with respect to dose homogeneity and conformality.
    Major T; Fodor J; Takácsi-Nagy Z; Agoston P; Polgár C
    Strahlenther Onkol; 2005 Feb; 181(2):89-96. PubMed ID: 15702297
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Different effects of bladder distention on point A-based and 3D-conformal intracavitary brachytherapy planning for cervical cancer.
    Ju SG; Huh SJ; Shin JS; Park W; Nam H; Bae S; Oh D; Hong CS; Kim JS; Han Y; Choi DH
    J Radiat Res; 2013 Mar; 54(2):349-56. PubMed ID: 23104899
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Commissioning of a grid-based Boltzmann solver for cervical cancer brachytherapy treatment planning with shielded colpostats.
    Mikell JK; Klopp AH; Price M; Mourtada F
    Brachytherapy; 2013; 12(6):645-53. PubMed ID: 23891341
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of bladder distention on bladder base dose in gynaecological intracavitary high dose rate brachytherapy.
    Adli M; Garipagaoglu M; Kocak Z
    Br J Radiol; 2009 Mar; 82(975):243-8. PubMed ID: 19064593
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dosimetric impact of interfraction catheter movement and organ motion on MRI/CT guided HDR interstitial brachytherapy for gynecologic cancer.
    Rey F; Chang C; Mesina C; Dixit N; Kevin Teo BK; Lin LL
    Radiother Oncol; 2013 Apr; 107(1):112-6. PubMed ID: 23333023
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MRI-based preplanning using CT and MRI data fusion in patients with cervical cancer treated with 3D-based brachytherapy: feasibility and accuracy study.
    Dolezel M; Odrazka K; Zizka J; Vanasek J; Kohlova T; Kroulik T; Spitzer D; Ryska P; Tichy M; Kostal M; Jalcova L
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):146-52. PubMed ID: 22300570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.